Related Experiment Video
Updated: Jul 2, 2025

Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products
Published on: December 5, 2020
Biological Activities of Secondary Metabolites from the Edible-Medicinal Macrofungi
Xiaoqi Sun1, Ying Shi1,2, Dongxiao Shi1
1State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
Abstract:
Macrofungi are well-known as edible-medicinal mushrooms, which belong mostly to Basidiomycota, with a few from Ascomycota. In recent years, macrofungi have been recognized as a rich resource of structurally unique secondary metabolites, demonstrating a wide range of bioactivities, including anti-tumor, antioxidant, anti-inflammatory, antimicrobial, antimalarial, neuro-protective, hypoglycemic, and hypolipidemic activities. This review highlights over 270 natural products produced by 17 families of macrofungi covering 2017 to 2023, including their structures, bioactivities, and related molecular mechanisms.
Related Concept Videos
Defenses Against Pathogens and Herbivores
The Roles of Bacteria and Fungi in Plant Nutrition

